Krilogy Financial’s Repros Therapeutics Inc. RPRX Stock Holding History

Krilogy Financial’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-500	Closed	–	–	848
2017 Q4	$0	Hold	500	–	–	﹤0.01%	883
2017 Q3	$0	Hold	500	–	–	﹤0.01%	890
2017 Q2	$0	Hold	500	–	–	﹤0.01%	828
2017 Q1	$1K	Hold	500	–	–	﹤0.01%	710
2016 Q4	$1K	Hold	500	–	–	﹤0.01%	710
2016 Q3	$1K	Hold	500	–	–	﹤0.01%	728
2016 Q2	$1K	Hold	500	–	–	﹤0.01%	744
2016 Q1	$1K	Hold	500	–	–	﹤0.01%	695
2015 Q4	$1K	Buy	+500	New	+$1.6K	﹤0.01%	421

Krilogy Financial's RPRX Position: Q1 2018 in Review

Krilogy Financial sold out of Repros Therapeutics Inc. (RPRX) in Q1 2018, closing a stake of 500 shares.

Krilogy Financial first reported a position in RPRX in Q4 2015 and held it in 9 quarters. The position peaked at $1K in Q1 2017. 1 fund tracked by Wall St. Rank holds RPRX as of Q1 2018.

Krilogy Financial reported no remaining Repros Therapeutics Inc. position as of Q1 2018 after selling out during the quarter.
Krilogy Financial sold 500 Repros Therapeutics Inc. shares in Q1 2018.
Krilogy Financial first reported a position in Repros Therapeutics Inc. in Q4 2015 and held it in 9 quarters.
Krilogy Financial's Repros Therapeutics Inc. position peaked at $1K in Q1 2017.
1 fund tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2018.

Based on Krilogy Financial's 13F filing for Q1 2018, filed 15 May 2018.